Quantum-Si (QSI) Stock: Buy, Sell, or Hold?
QSI - Quantum-Si Incorporated Class A Common Stock
$1.55
0.12 (8.39%)
▲
5d:
+85.78%
30d:
+103.68%
90d:
+62.87%
WAIT
LOW Confidence
Analysis Updated: Oct 2, 2026 12:00 AM ET
Earnings: Nov 04, 2026
Get Alerted When QSI Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR BETTER ENTRY: QSI is 50.5% above its trading range ($1.03). While momentum could continue, risk/reward favors waiting for a pullback.
⏸️ WAIT FOR BETTER ENTRY: QSI is 50.5% above its trading range ($1.03). While momentum could continue, risk/reward favors waiting for a pullback.
In-depth Analysis How we analyze
Valuation Analysis: QSI is currently trading at $1.55, which is considered extended relative to its 30-day fair value range of $0.64 to $1.03.
Technical Outlook: Technically, QSI is in a strong downtrend. The price is approaching resistance at $1.55. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 8.4% recently.
Market Sentiment: QSI scores 15/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $2.28 (+47.3%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, QSI is in a strong downtrend. The price is approaching resistance at $1.55. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 8.4% recently.
Market Sentiment: QSI scores 15/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $2.28 (+47.3%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$0.64 -
$1.03
Company Quality Score
36/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
21.1%
All Signals
- BEARISH: Price significantly overextended (+50.5% above its trading range)
- BEARISH: Weak technical setup (15/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+8.4%)
- BULLISH: Trading 47.3% below Wall St target ($2.28)
- WARNING: Composite score 36/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$0.64 -
$1.03
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$0.74
Resistance Level
$1.55
Current Trend
Strong Downtrend
Technical data as of
Oct 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-4.43
Wall Street Target
$2.28
(+47.3%)
Revenue Growth (YoY)
-41.8%
Share & Embed Analysis
Last updated: October 03, 2026 11:16 AM ET
Data refreshes hourly during market hours. Next update: 12:16 PM
Data refreshes hourly during market hours. Next update: 12:16 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is QSI showing a specific setup today?
Insider Activity (6 Months)
0
Buys
3
Sells
Net
INSIDERS SELLING
Recent Transactions
Jeffry R Keyes
SELL
37381 shares
2026-04-21
Jeffrey Alan Hawkins
SELL
83712 shares
2026-04-20
Jeffry R Keyes
SELL
37382 shares
2026-04-20
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
SYK
Stryker Corporation |
BUY
32 analysts |
$369 | 69 BUY |
|
DXCM
DexCom Inc |
STRONG BUY
27 analysts |
$94 | 47 HOLD |
|
EW
Edwards Lifesciences Corp |
HOLD
32 analysts |
$101 | 58 HOLD |
|
ABT
Abbott Laboratories |
STRONG BUY
27 analysts |
$120 | 38 SELL |
|
GEHC
GE HealthCare Technologi… |
STRONG BUY
21 analysts |
$83 | 60 BUY |
